Wearable Phototherapy

Wearable Phototherapy

60 percent of all newborns develop jaundice. 10 percent require therapy to avoid potential neurological damage. But common practice often requires hospitalization, leading to delayed discharge or readmission, mainly in the first week of life. During the treatment with blue light the baby is naked and blinded in a cot. A study conducted on "Maternal Experience with Neonatal Jaundice" described the experiences: physical and emotional exhaustion, feeling robbed, distressed by infant's physical appearance, loss of control, maternal vigilance and negative family impact. Bilihome's wearable phototherapy is designed to support both parents and child as much as possible with their natural care routines. For example, the wearable device can be worn by the baby during breastfeeding, skin-to-skin contact and even when the baby is being carried around.